Please Wait
Applying Filters...
menu
    • menu

    List of Written Confirmation(s) issued for Hyospaz Active Pharmaceutical Ingredient (API)

    Client Email Product
    US, Europe turn to advanced manufacturing, stockpiling to strengthen drug supply chains

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Sept 2024: BMS wins landmark FDA approval for schizophrenia med; Sanofi’s Dupixent okayed for COPD

    Stock Recap
    #PipelineProspector

    Menu

    Hyospaz

    ACTIVE PHARMA INGREDIENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 14,318Xls download

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Name of the Firm Written Confirmation No. Product Name Issue Date Valid Till Address of the Firm
    17/10/2022 Alchem International Private Ltd
    India
    		 M/s. Alchem International Private Limited WC-0006 Hyoscyamine Sulphate EP/USP & Hyoscyamine Hydrobromide USP 2022-05-27 2025-05-26 25/2, Main Mathura Road, Village Kalli, Ballabgarh, Faridabad-121 004, Haryana, India
    26/06/2021 Vital Laboratories Private Limited
    India
    		 M/s Vital Laboratories Pvt ltd WC-0300 Hyoscyamine Sulfate EP 2021-04-01 2024-01-08 Plot no.1710 & A1-2208 GIDC Estate 3rd Phase, Vapi Gujarat 396195